logo
Sign in

STAA Stock Price, Chart, Stats & News

STAAR Surgical Company
Save
1.55B
Market cap
54.75x
Current P/E
123.46x
Forward P/E

STAA chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
75.63%
Operating margin
-33.31%
Pretax margin
-34.36%
Net margin
-33.60%
Effective tax rate
2.21%
ROA
-17.43%
ROE
-23.24%
D/E
0.11x
Interest coverage ratio

STAA valuation

P/E
54.75x
P/S
3.70x
P/B
2.58x
P/CF
-25.91x
P/FCF
-22.12x
P/OCF
-25.91x
PEG
-0.65x
EV multiple
-26.70x

About

STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness.

Similar securities

Based on sector and market capitalization

Report issue